patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody
cadonilimab
Phase 2updated 2mo agoby Akeso Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 40 investigational indications.
targets
Programmed cell death protein 1Cytotoxic T-lymphocyte protein 4
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that